logo
logo

Amplifybio Acquires Pact Pharma Assets To Enhance Cell And Gene Therapy Characterization Capabilities

Oct 03, 2022almost 3 years ago

Acquiring Company

AmplifyBio, LLC

Acquired Company

PACT PHARMA ASSETS

West JeffersonBiotechnology

Description

AmplifyBio, a contract research organization (CRO) focused on accelerating innovation across pharmaceutical modalities; today announced the acquisition of select assets from PACT Pharma, Inc., a privately held biopharmaceutical company developing neoantigen-specific T cell receptor cell therapies. The deal will provide AmplifyBio with advanced characterization platforms, bioinformatics capabilities, and 40 drug development experts to enhance their cell and gene therapy service offerings. AmplifyBio will also acquire the South San Francisco advanced laboratory space.

Company Information

Company

AmplifyBio, LLC

Location

1425 PLAIN CITY-GEORGESVILLE ROAD

West Jefferson, Ohio, United States

About

AmplifyBio combines the strength, knowledge and experience of our partners, and the expertise of our cross-integrated teams to advance translational science, cell and gene therapies and next-generation medicines for the benefit of millions of people around the world. Our facilities include a state-of-the-art fully functional GLP lab with 200,000 sq of space dedicated to drug development including a full complement of pre-clinical models and support services.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed

Related People

Kelly hidden

hidden
hidden

Jaehyung hidden